H
Helius Therapeutics
Designed a state-of-the-art facility in Auckland with controlled growing systems, integrated extraction site, advanced cannabinoid research laboratories and manufacturing operations
About Helius Therapeutics
Helius Therapeutics is a pioneering biotechnology company focused on the research, development, and production of next-generation cannabinoid medicines. Operating primarily in New Zealand, Helius Therapeutics serves healthcare professionals and patients seeking effective medicinal cannabis solutions. The company integrates cutting-edge medical research with innovative product development to create safe and efficacious cannabis-based medicines. Helius Therapeutics generates revenue through the sale of its verified medicinal cannabis products, which meet the Ministry of Health's quality standards. The business model includes providing comprehensive resources for healthcare professionals, such as prescriber resources, product information sheets, clinical summaries, and therapeutic treatment areas. By leveraging its expertise in natural cannabis compounds and novel delivery systems, Helius aims to improve the quality of life for its clients.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Auckland, New Zealand
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 59.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Cannabis, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2026 | $0 | — | Ora Pharm | ↗ |
| EARLY VC✓Equity / VC | Jan 2021 | $9.7M | $39M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Helius Therapeutics is 4.3K monthly website visits, down 32.8% over the last three months. Helius Therapeutics's team declined 52.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Helius Therapeutics in the Auckland ecosystem
The Helius Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Ora Pharm
Guy Haddleton
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Helius Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Helius Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










